Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(1.91)
# 3,180
Out of 4,976 analysts
207
Total ratings
25%
Success rate
-2.63%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.05 | +757.14% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.70 | +1,046.95% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $5.10 | +272.55% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $2.12 | +88.68% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $2.14 | -6.54% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $8 | $0.39 | +1,956.56% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $2.84 | +569.01% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $2.42 | +767.77% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.41 | +963.83% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $56 | $0.67 | +8,208.61% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.90 | +1,012.22% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.44 | +350.86% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.55 | +559.34% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $7.73 | +145.80% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.58 | +520.16% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.97 | +516.65% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.22 | +8,096.72% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.66 | +2,646.41% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.27 | +781.06% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $4.12 | +382,181.55% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $22.85 | +2,088.18% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $18.76 | +1,179.32% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.71 | +4,578.36% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $0.96 | +10,305.83% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $6.04 | +132,350.33% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.37 | +410.95% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $2.40 | +1,150.00% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $2.93 | +1,265.19% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $10.35 | +73.91% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $4.64 | +7.76% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $5.20 | +27,592.31% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $52.09 | -53.93% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $1.37 | +249,553.26% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $1.44 | +1,319,344.44% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.05
Upside: +757.14%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.70
Upside: +1,046.95%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $5.10
Upside: +272.55%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $2.12
Upside: +88.68%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $2.14
Upside: -6.54%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $8
Current: $0.39
Upside: +1,956.56%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $2.84
Upside: +569.01%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $2.42
Upside: +767.77%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.41
Upside: +963.83%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $56
Current: $0.67
Upside: +8,208.61%
Mar 6, 2025
Reiterates: Buy
Price Target: $10
Current: $0.90
Upside: +1,012.22%
Mar 5, 2025
Reiterates: Buy
Price Target: $2
Current: $0.44
Upside: +350.86%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $4.55
Upside: +559.34%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $7.73
Upside: +145.80%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $2.58
Upside: +520.16%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.97
Upside: +516.65%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $1.22
Upside: +8,096.72%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $0.66
Upside: +2,646.41%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.27
Upside: +781.06%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $4.12
Upside: +382,181.55%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $22.85
Upside: +2,088.18%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $18.76
Upside: +1,179.32%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $1.71
Upside: +4,578.36%
Jun 30, 2021
Initiates: Buy
Price Target: $100
Current: $0.96
Upside: +10,305.83%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $6.04
Upside: +132,350.33%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.37
Upside: +410.95%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $2.40
Upside: +1,150.00%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $2.93
Upside: +1,265.19%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $10.35
Upside: +73.91%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $4.64
Upside: +7.76%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $5.20
Upside: +27,592.31%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $52.09
Upside: -53.93%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $1.37
Upside: +249,553.26%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $1.44
Upside: +1,319,344.44%